Long-Term GAD-alum Treatment Effect on Different T-Cell Subpopulations in Healthy Children Positive for Multiple Beta Cell Autoantibodies

OBJECTIVE: The objective of this study was to explore whether recombinant GAD65 conjugated hydroxide (GAD-alum) treatment affected peripheral blood T-cell subpopulations in healthy children with multiple beta cell autoantibodies. METHOD: The Diabetes Prevention–Immune Tolerance 2 (DiAPREV-IT 2) clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Salami, Falastin, Spiliopoulos, Lampros, Maziarz, Marlena, Lundgren, Markus, Brundin, Charlotte, Bennet, Rasmus, Hillman, Magnus, Törn, Carina, Elding Larsson, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159828/
https://www.ncbi.nlm.nih.gov/pubmed/35664355
http://dx.doi.org/10.1155/2022/3532685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159828/
https://www.ncbi.nlm.nih.gov/pubmed/35664355
http://dx.doi.org/10.1155/2022/3532685

Ejemplares similares